Zeming Chen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Large language models (LLMs) are deep learning algorithms trained on vast amounts of text to learn billions of mathematical relationships between words (also called ‘parameters’). They are familiar to most of us as the algorithmic basis for chatbots like OpenAI’s ChatGPT and PaLM, used for Google’s Bard. Today’s largest models have hundreds of billions of parameters, also costing in the billions of dollars to train.

Large language models (LLMs) are deep learning algorithms trained on vast amounts of text to learn billions of mathematical relationships between words (also called ‘parameters’). They are familiar to most of us as the algorithmic basis for chatbots like OpenAI’s ChatGPT and PaLM, used for Google’s Bard. Today’s largest models have hundreds of billions of parameters, also costing in the billions of dollars to train.

Meditron is a suite of open-source medical Large Language Models (LLMs). - GitHub - epfLLM/meditron: Meditron is a suite of open-source medical Large Language Models (LLMs).

Stroke-Targeting Nanoparticles Deliver Neuroprotectant to Mouse Brain Written by AZoNanoMar 12 2021 According to a new study, the delivery of NA1, a neuroprotectant, to the brain in nanoparticles decreases stroke severity and enhances survival in a mouse model of stroke. Image Credit: Alexandros A Lavdas/shutterstock.com This is a preliminary study to be presented at the American Stroke Association’s International Stroke Conference 2021. The virtual meeting will be held from March 17 th to 19 th, 2021, and is a world premiere meeting for clinicians and researchers committed to the science ...

 E-Mail DALLAS, March 11, 2021 -- When NA1, a neuroprotectant, was delivered to the brain in nanoparticles, it reduced stroke severity and improved survival in a mouse model of stroke, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2021. The virtual meeting is March 17-19, 2021 and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health. In an earlier human trial (the ESCAPE-NA1 trial), NA1, a small peptide designed to save brain cells from death after stroke, showed ...